BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sakae TM, Pizzichini MM, Teixeira PJ, Silva RM, Trevisol DJ, Pizzichini E. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol 2013;39:259-71. [PMID: 23857694 DOI: 10.1590/S1806-37132013000300002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Marshall S, McCann AJ, Samuels TL, Blair A, Bonne V, Johnston N, Koufman J. Detection of pepsin and IL-8 in saliva of adult asthmatic patients. J Asthma Allergy 2019;12:155-61. [PMID: 31213853 DOI: 10.2147/JAA.S205482] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management. Semin Respir Crit Care Med 2015;36:575-91. [PMID: 26238643 DOI: 10.1055/s-0035-1556063] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
3 Halner A, Beer S, Pullinger R, Bafadhel M, Russell REK. Predicting treatment outcomes following an exacerbation of airways disease. PLoS One 2021;16:e0254425. [PMID: 34415919 DOI: 10.1371/journal.pone.0254425] [Reference Citation Analysis]
4 Baldomero AK, Wendt CH, Petersen A, Gaeckle NT, Han MK, Kunisaki KM; COPDGene Investigators. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort. Respir Res. 2020;21:203. [PMID: 32746820 DOI: 10.1186/s12931-020-01469-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis 2014;9:871-88. [PMID: 25210449 DOI: 10.2147/COPD.S49621] [Cited by in Crossref: 130] [Cited by in F6Publishing: 87] [Article Influence: 16.3] [Reference Citation Analysis]
6 Huang C, Liu Y, Shi G. A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med 2020;20:2. [PMID: 31914979 DOI: 10.1186/s12890-019-1027-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Recio Iglesias J, Díez-Manglano J, López García F, Díaz Peromingo JA, Almagro P, Varela Aguilar JM. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. Int J Chron Obstruct Pulmon Dis 2020;15:1015-37. [PMID: 32440113 DOI: 10.2147/COPD.S242009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lee AL, Goldstein RS. Gastroesophageal reflux disease in COPD: links and risks. Int J Chron Obstruct Pulmon Dis 2015;10:1935-49. [PMID: 26392769 DOI: 10.2147/COPD.S77562] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
9 Erdal M, Johannessen A, Eagan TM, Bakke P, Gulsvik A, Grønseth R. Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. Int J Chron Obstruct Pulmon Dis 2016;11:2099-108. [PMID: 27621614 DOI: 10.2147/COPD.S108720] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Ajmera M, Raval AD, Shen C, Sambamoorthi U. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. Int J Chron Obstruct Pulmon Dis 2014;9:339-48. [PMID: 24748785 DOI: 10.2147/COPD.S59139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
11 Tan J, Li L, Huang X, Yang C, Liang X, Zhao Y, Xie J, Chen R, Wang D, Xie S. Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses. BMJ Open 2020;10:e038450. [PMID: 33380477 DOI: 10.1136/bmjopen-2020-038450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Jung YH, Lee DY, Kim DW, Park SS, Heo EY, Chung HS, Kim DK. Clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1343-51. [PMID: 26203240 DOI: 10.2147/COPD.S84337] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Su VY, Liao HF, Perng DW, Chou YC, Hsu CC, Chou CL, Chang YL, Yen JC, Chen TJ, Chou TC. Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD. Int J Chron Obstruct Pulmon Dis 2018;13:2907-15. [PMID: 30275689 DOI: 10.2147/COPD.S157761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yoon HY, Park SY, Lee CH, Byun MK, Na JO, Lee JS, Lee WY, Yoo KH, Jung KS, Lee JH. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis. Int J Chron Obstruct Pulmon Dis 2019;14:1389-97. [PMID: 31388298 DOI: 10.2147/COPD.S205517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Hackett AP, Trinick RE, Rose K, Flanagan BF, McNamara PS. Weakly acidic pH reduces inflammatory cytokine expression in airway epithelial cells. Respir Res 2016;17:82. [PMID: 27422381 DOI: 10.1186/s12931-016-0399-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
16 Sanchez J, Schumann DM, Karakioulaki M, Papakonstantinou E, Rassouli F, Frasnelli M, Brutsche M, Tamm M, Stolz D. Laryngopharyngeal reflux in chronic obstructive pulmonary disease - a multi-centre study. Respir Res 2020;21:220. [PMID: 32825819 DOI: 10.1186/s12931-020-01473-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Husebø GR, Bakke PS, Aanerud M, Hardie JA, Ueland T, Grønseth R, Persson LJ, Aukrust P, Eagan TM. Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study. PLoS One 2014;9:e109721. [PMID: 25279458 DOI: 10.1371/journal.pone.0109721] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
18 Xiong W, Zhang QS, Zhao W, Ding W, Liu JM, Zhao YF. A 12-month follow-up study on the preventive effect of oral lansoprazole on acute exacerbation of chronic obstructive pulmonary disease. Int J Exp Pathol 2016;97:107-13. [PMID: 27135904 DOI: 10.1111/iep.12173] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
19 Hanlon P, Nicholl BI, Jani BD, McQueenie R, Lee D, Gallacher KI, Mair FS. Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. BMJ Open 2018;8:e018404. [PMID: 29332840 DOI: 10.1136/bmjopen-2017-018404] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
20 Liu H. Assessment of anti-reflux treatment on pulmonary ventilation function and inflammatory cytokines in patients with stable chronic obstructive pulmonary disease combined with gastroesophageal reflux. Exp Ther Med 2018;15:5528-36. [PMID: 29844808 DOI: 10.3892/etm.2018.6077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 McDonnell MJ, Hunt EB, Ward C, Pearson JP, O'Toole D, Laffey JG, Murphy DM, Rutherford RM. Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review. ERJ Open Res 2020;6:00190-2019. [PMID: 33693049 DOI: 10.1183/23120541.00190-2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]